Status Epilepticus: An Update on Pharmacological Management.

Area of Science:

• Neurology
• Pharmacology

Background:

• Status epilepticus (SE) is a time-sensitive neurological emergency requiring prompt treatment.
• Treatment strategies for SE are staged according to the time elapsed and clinical phase.

Purpose of the Study:

• To outline the pharmacological treatment approach for status epilepticus (SE).
• To describe the progression of SE treatment through emergent, urgent, and refractory phases.

Main Methods:

• Review of current pharmacological interventions for SE.
• Categorization of treatments based on SE phases: emergent, urgent, and refractory.

Main Results:

• Benzodiazepines are the first-line treatment in the emergent phase of SE.
• Antiseizure medications (phenytoin, valproic acid, levetiracetam) are recommended for the urgent phase, with individualized selection based on patient factors.
• Anesthetic infusions (midazolam, propofol, pentobarbital, ketamine) are used for refractory SE (RSE).

Conclusions:

• The optimal pharmacotherapeutic strategies for refractory SE and superrefractory SE remain undefined.
• Individualized patient characteristics are crucial for selecting antiseizure medications in the urgent phase.